Sort
53,477 grants matching “addiction”
COBRE PHASE III: Center for Neuroplasticity at the University of Puerto Rico
$1,054,473Jose A Lasalde-Dominicci · University Of Puerto Rico Med Sciences · P30 · FY2025 · GM
Investigation On The Behavior And Related Neuro-Electrochemistry Of Potential Medications For The Treatment Of Substance Use Disorders.
$1,054,088Gianluigi Tanda · National Institute On Drug Abuse · ZIA · FY2020 · DA
Endocannabinoid Active Sites as Therapeutic Targets
$1,053,894Alexandros Makriyannis · Northeastern University · P01 · FY2010 · DA
Effects of Sleep Disruption on Subjective Responses to Opioid Administration in Patients with Chronic Pain
$1,053,798Michael T Smith · Johns Hopkins University · R01 · FY2023 · DA
Presynaptic Mechanisms of Neural Plasticity
$1,053,442Robert H Edwards · University Of California, San Francisco · P01 · FY2015 · DA
Center on Molecular and Cell Biology of Drug Abuse
$1,053,158Horace H Loh · University Of Minnesota · P50 · FY2007 · DA
Center on Molecular and Cell Biology of Drug Abuse
$1,053,021Horace H Loh · University Of Minnesota · P50 · FY2006 · DA
COBRE PHASE III: Center for Neuroplasticity at the University of Puerto Rico
$1,053,013Jose A Lasalde-Dominicci · University Of Puerto Rico Med Sciences · P30 · FY2024 · GM
Presynaptic Mechanisms of Neural Plasticity
$1,052,626Robert H Edwards · University Of California, San Francisco · P01 · FY2016 · DA
Biological And Biochemical Characterization Of Sigma Receptors
$1,052,586Tsung-Ping Ping Su · National Institute On Drug Abuse · ZIA · FY2009 · DA
Polyclonal Bi-Specific Vectored ImmunoTherapy to Functionally Cure HIV Infection
$1,052,100Alejandro Benjamin Balazs · Massachusetts General Hospital · DP1 · FY2024 · DA
Polyclonal Bi-Specific Vectored ImmunoTherapy to Functionally Cure HIV Infection
$1,052,100Alejandro Benjamin Balazs · Massachusetts General Hospital · DP1 · FY2025 · DA
Endocannabinoid Active Sites as Therapeutic Targets
$1,051,850Alexandros Makriyannis · Northeastern University · P01 · FY2011 · DA
IGF::OT::IGF PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS PERIOD OF PERFORMANCE 9/1/2015 - 2/29/2016: TASK ORDER 3 AWARD
$1,051,567Brian Thomas · Research Triangle Institute · N01 · FY2017 · DA
Project 3: Randomized Placebo-controlled Trial of Nicotine Pouches in Smokers
$1,050,903Jonathan Foulds · Pennsylvania State Univ Hershey Med Ctr · U54 · FY2024 · DA
Discovery, Regulation and Function of the PI 3-Kinase and AKT Pathway in Cancer
$1,050,000Alex Toker · Beth Israel Deaconess Medical Center · R35 · FY2025 · CA
Clinical Trials Network: Pacific Northwest Node
$1,049,999Mary Akiko Hatch · University Of Washington · UG1 · FY2020 · DA
Novel biologic to treat chemotherapy-induced neuropathic pain
$1,049,997Yakov Kogan · Raft Pharmaceuticals, Llc · R44 · FY2023 · CA
Advancing a Holistic Understanding of Variability in Lived Experience with Sickle Cell Pain
$1,049,682Charmaine Dawn Marie Royal · Duke University · R01 · FY2025 · HL
MOLECULAR GENETICS OF HEROIN DEPENDENCE
$1,048,527Massachusetts Mental Health Institute · R01 · FY2003 · DA
Impact of Marijuana Legalization: Comparison of Two Longitudinal Twin Cohorts
$1,048,232Christian J Hopfer · University Of Colorado Denver · R01 · FY2020 · DA
SCOR Application on Sex, Stress, and Cocaine Addiction
$1,048,193Yale University · P50 · FY2002 · DA
HIV Disease Outcomes in Drug Users in Clinical Practice
$1,047,335Richard Douglas Moore · Johns Hopkins University · R01 · FY2007 · DA
NICOTINIC CHOLINERGIC SYSTEMS IN MUTANT MICE
$1,047,242Baylor College Of Medicine · P01 · FY2000 · DA
Clinical Trials Network: The Texas Node
$1,047,032Madhukar H Trivedi · Ut Southwestern Medical Center · U10 · FY2014 · DA